Authors
Latest:
Palliative Care: Let’s Keep the Conversation OpenAs the end of my hematology/oncology fellowship draws near, I am reminded every day that oncology is not about winning or losing.
Latest:
The Goodwill of Strangers Helps Build a Unique Resource for Cancer ResearchThousands of women have made the selfless choice to literally donate a precious piece of themselves by giving a breast tissue sample to the Susan G. Komen Tissue Bank at the Indiana University Melvin and Bren Simon Cancer Center, a unique resource for researchers worldwide.
Latest:
Anna Vioral on Multidisciplinary Chemotherapy Safety StandardsAnna Vioral, RN, OCN, from West Penn Allegheny Health System, on Multidisciplinary Chemotherapy Safety Standards.
Latest:
Chiang Contextualizes the Optimal Use of Lurbinectedin in SCLC ManagementDr Chiang discusses the use of lurbinectedin in small cell lung cancer and tips for managing toxicities associated with this agent.
Latest:
Redefining SCLC: Molecular Subtypes and Blood Biomarkers Guide TherapyKey opinion leaders investigate the potential impact of redefining small cell lung cancer (SCLC) as a molecularly heterogeneous malignancy on personalized treatment strategies for SCLC subtypes with distinct therapeutic vulnerabilities, while exploring the emerging role of blood-based biomarkers in shaping the evolving treatment landscape for SCLC.
Latest:
Dr. Covey on Recent and Future Changes to the NCCN Guidelines for HCCAnne Covey, MD, interventional radiologist, Memorial Sloan Kettering Cancer Center, discusses recent and future changes to locoregional treatment approaches for hepatocellular carcinoma (HCC).
Latest:
Dr. Favret on Extending Survival and Improving Outcomes in Breast CancerAnne Favret, MD, discusses the importance of clinical trials in the breast cancer space.
Latest:
Why Radiation Oncology Needs an APMAlternative payment models (APMs) are the future of Medicare payment.
Latest:
Dr. Klompenhouwer on the Resection of Larger Hepatocellular AdenomasAnne Julia Klompenhouwer, MD, Department of Surgery at Erasmus Medical Center in Rotterdam, The Netherlands, discusses when it is justified to resect a larger hepatocellular adenoma for patients with hepatocellular carcinoma (HCC).
Latest:
Anne Katz Discusses Cancer and SexualityAnne Katz, from the University of Manitoba, Discusses Cancer and Sexuality
Latest:
Supporting Adolescents and Young Adults With Cancer From Diagnosis Through SurvivorshipDue to the unique characteristics of adolescents and young adults, there is a growing effort to address their oncology needs.
Latest:
Dr. Anne Marie McCarthy on Measuring Breast Density with Computer AlgorithmsAnne Marie McCarthy, MD, research fellow, Massachusetts General Hospital, discusses using computer algorithms to measure breast density.
Latest:
Dr. McTiernan on Biomarkers in Breast CancerAnne McTiernan, MD, PhD, research professor of epidemiology, University of Washington, member, Fred Hutchinson Cancer Research Center, discusses the biomarkers that are associated with poor prognosis in patients with breast cancer.
Latest:
Dr. Odisho on a Risk Prediction Model in Renal Cell CarcinomaAnobel Odisho, MD, urologic oncology fellow, University of Washington, discusses the use of a risk prediction model for patients with renal cell carcinoma.
Latest:
The Personal Touch: Patients Are More Than Their ChartsAnthony Accurso, MD, offers a patient more time managing their cancer and a better quality of life.
Latest:
Dr El-Khoueiry on Regorafenib/Pembrolizumab in Advanced HCC After Prior Anti–PD-1/L1 TherapyAnthony B. El-Khoueiry, MD, on data for regorafenib plus pembrolizumab in pretreated advanced hepatocellular carcinoma.
Latest:
Testing Reveals Extent of Lynch SyndromeThe presence of Lynch syndrome correlates with microsatellite-instability status and DNA mismatch-repair deficiency across a variety of tumor types.
Latest:
Phase II Clinical Trial of Intratumoral Dendritic Cells Injections and Neoadjuvant Radiotherapy in Resectable Soft Tissue SarcomasNeoadjuvant radiation with dendritic cell injections has the potential to be safe, effective, and immunogenic in high-grade soft tissue sarcoma and needs to be confirmed in randomized larger clinical trials.
Latest:
Dr. Costales on Study of Adjuvant Therapy in Uterine LeiomyosarcomaAnthony Costales, MD, gynecologic oncology fellow, Cleveland Clinic, discusses a study of adjuvant therapy for patients with uterine leiomyosarcoma.
Latest:
Dr. Elias on Androgen Receptor Inhibitors in HER2-Positive Breast CancerAnthony D. Elias, MD, professor, Division of Medical Oncology, University of Colorado School of Medicine, discusses using androgen receptor inhibitors as a potential treatment of patients with HER2-positive breast cancer.
Latest:
Discussion of RESORCE TrialPanelists discuss the data from the RESORCE trial, highlighting the efficacy of regorafenib in previously treated hepatocellular carcinoma, including primary trial results and insights on time to progression based on prior sorafenib treatment.
Latest:
Drs El-Khoueiry and Hughes-Halbert on the Importance of a Multidisciplinary Approach in Cancer CareAnthony B. El-Khoueiry, MD, and Chanita Hughes-Halbert, PhD, discuss their role within the Stand Up To Cancer® 4-team initiative, focusing on diversity in early-phase clinical trials.
Latest:
BCL-2 Inhibitors May Provide Avenue of Attack Against High-Risk NeuroblastomaInvestigators at Virginia Commonwealth University Massey Cancer Center discuss the current treatment for children with high-risk neuroblastoma including high-dose chemotherapy, surgery, stem cell transplantation, radiation therapy, isotretinoin, and immunotherapy.
Latest:
CMS Unveils Proposed Radiation Oncology Model of CareUntil now, radiation oncology (RO) has remained largely untouched by the valuebased initiatives of the Centers for Medicare and Medicaid Services. The federal agency aims to change that with a proposed RO Model of care that would promote site-neutral payment and take away incentives for volume-based billing.
